Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 84.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,119 shares of the company's stock after buying an additional 32,142 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Option Care Health were worth $2,195,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. UMB Bank n.a. raised its stake in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC increased its position in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after purchasing an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after purchasing an additional 1,446 shares in the last quarter. International Assets Investment Management LLC increased its position in shares of Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after purchasing an additional 2,757 shares in the last quarter. Finally, Blue Trust Inc. increased its position in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock worth $81,000 after purchasing an additional 377 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.
Option Care Health Trading Up 0.3 %
Shares of Option Care Health stock traded up $0.06 during trading hours on Wednesday, hitting $23.65. The company's stock had a trading volume of 642,482 shares, compared to its average volume of 1,550,704. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63. The firm has a fifty day moving average of $26.53 and a 200-day moving average of $28.79. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 19.82, a P/E/G ratio of 2.50 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.
Analyst Upgrades and Downgrades
Several brokerages recently commented on OPCH. Jefferies Financial Group cut Option Care Health from a "buy" rating to a "hold" rating and dropped their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Bank of America cut Option Care Health from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. JMP Securities boosted their price target on Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research report on Monday, September 30th. Truist Financial dropped their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a report on Friday, November 1st. Finally, Barrington Research dropped their target price on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $30.83.
Check Out Our Latest Analysis on OPCH
Insider Buying and Selling
In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.64% of the stock is owned by corporate insiders.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.